Arkansas Children's Hospital — Little Rock, Arkansas

Public research footprint of Arkansas Children's Hospital, compiled from the ClinicalTrials.gov public registry.

544

Registered studies

188

Active

Recruiting now

284

Completed

Stopped or withdrawn

Most-studied conditions

B Acute Lymphoblastic Leukemia · Botryoid-Type Embryonal Rhabdomyosarcoma · Classic Hodgkin Lymphoma · Spindle Cell Rhabdomyosarcoma

Recently updated registry entries

NCT04320888 — Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic… (Active Not Recruiting)
NCT03907488 — Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in… (Active Not Recruiting)
NCT03253263 — A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Arkansas Children's Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.